175 related articles for article (PubMed ID: 30678968)
41. PLGA-Based Nanoplatforms in Drug Delivery for Inhibition and Destruction of Microbial Biofilm.
Shariati A; Chegini Z; Ghaznavi-Rad E; Zare EN; Hosseini SM
Front Cell Infect Microbiol; 2022; 12():926363. PubMed ID: 35800390
[TBL] [Abstract][Full Text] [Related]
42. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
[TBL] [Abstract][Full Text] [Related]
43. In vitro antibacterial activity and cytocompatibility of magnesium-incorporated poly(lactide-co-glycolic acid) scaffolds.
Ma R; Wang W; Yang P; Wang C; Guo D; Wang K
Biomed Eng Online; 2020 Feb; 19(1):12. PubMed ID: 32070352
[TBL] [Abstract][Full Text] [Related]
44. Preparation, Characterization, and Antibacterial Effects of Chitosan Nanoparticles Embedded with Essential Oils Synthesized in an Ionic Liquid Containing System.
Wu J; Shu Q; Niu Y; Jiao Y; Chen Q
J Agric Food Chem; 2018 Jul; 66(27):7006-7014. PubMed ID: 29878760
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
46. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
[TBL] [Abstract][Full Text] [Related]
47. Formulation, optimization, hemocompatibility and pharmacokinetic evaluation of PLGA nanoparticles containing paclitaxel.
Mittal P; Vardhan H; Ajmal G; Bonde GV; Kapoor R; Mittal A; Mishra B
Drug Dev Ind Pharm; 2019 Mar; 45(3):365-378. PubMed ID: 30394795
[TBL] [Abstract][Full Text] [Related]
48. Enhanced Cellular Cytotoxicity and Antibacterial Activity of 18-β-Glycyrrhetinic Acid by Albumin-conjugated PLGA Nanoparticles.
Darvishi B; Manoochehri S; Esfandyari-Manesh M; Samadi N; Amini M; Atyabi F; Dinarvand R
Drug Res (Stuttg); 2015 Dec; 65(12):617-23. PubMed ID: 25607747
[TBL] [Abstract][Full Text] [Related]
49. Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa.
Sabaeifard P; Abdi-Ali A; Soudi MR; Gamazo C; Irache JM
Eur J Pharm Sci; 2016 Oct; 93():392-8. PubMed ID: 27575877
[TBL] [Abstract][Full Text] [Related]
50. Anti-
Simonetti G; Palocci C; Valletta A; Kolesova O; Chronopoulou L; Donati L; Di Nitto A; Brasili E; Tomai P; Gentili A; Pasqua G
Molecules; 2019 May; 24(11):. PubMed ID: 31151290
[TBL] [Abstract][Full Text] [Related]
51. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of Poly-Lactic-Co-Glycolic Acid Micro- and Nanoparticles of Ciprofloxacin Against Bacterial Biofilms.
Thomas N; Thorn C; Richter K; Thierry B; Prestidge C
J Pharm Sci; 2016 Oct; 105(10):3115-3122. PubMed ID: 27519649
[TBL] [Abstract][Full Text] [Related]
53. Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori.
Lotfipour F; Valizadeh H; Milani M; Bahrami N; Ghotaslou R
Drug Res (Stuttg); 2016 Jan; 66(1):41-5. PubMed ID: 25919643
[TBL] [Abstract][Full Text] [Related]
54. Chitosan-propolis nanoparticle formulation demonstrates anti-bacterial activity against Enterococcus faecalis biofilms.
Ong TH; Chitra E; Ramamurthy S; Siddalingam RP; Yuen KH; Ambu SP; Davamani F
PLoS One; 2017; 12(3):e0174888. PubMed ID: 28362873
[TBL] [Abstract][Full Text] [Related]
55. Electron microscopy of Staphylococcus epidermidis fibril and biofilm formation using image-enhancing ionic liquid.
Takahashi C; Kalita G; Ogawa N; Moriguchi K; Tanemura M; Kawashima Y; Yamamoto H
Anal Bioanal Chem; 2015 Feb; 407(6):1607-13. PubMed ID: 25542577
[TBL] [Abstract][Full Text] [Related]
56. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
57. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y
J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150
[TBL] [Abstract][Full Text] [Related]
58. Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs.
Lee BS; Lee CC; Wang YP; Chen HJ; Lai CH; Hsieh WL; Chen YW
Int J Nanomedicine; 2016; 11():285-97. PubMed ID: 26848264
[TBL] [Abstract][Full Text] [Related]
59. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
60. Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles.
Mustafa S; Devi VK; Pai RS
Drug Deliv Transl Res; 2017 Feb; 7(1):27-36. PubMed ID: 27576453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
